The founder, chairman, and CEO of Celularity shared his view on the concept of “chimeric vigor” and the potential benefits arising from it in the cell therapy field.
Robert J. Hariri, MD, PhD
Advertisement
Articles by Robert J. Hariri, MD, PhD
The founder, chairman, and CEO of Celularity shared his view on the importance of cord blood-derived cells for the medical and clinical community.
The founder, chairman, and CEO of Celularity discussed the advantages of cells derived from umbilical cord blood versus other sources of cells for cell therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 17, 2025
2
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
3
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
4
Guess the Therapy Answer December 17, 2025
5